Research

Mixed

FMT shows promise in treating Inflammatory Bowel Disease (IBD), including Ulcerative Colitis (UC) and Crohn's Disease (CD), but efficacy is lower and more variable than in CDI, with clinical remission rates around 36-45% in systematic reviews.

For those with Ulcerative Colitis or Crohn's Disease who haven't responded well to standard treatments, FMT might be an option. While not as consistently effective as for C. diff, some patients do achieve remission, especially younger individuals. It requires careful consideration of the risks and benefits, and multiple treatments may be needed.

ModerateQualifiesMEDIUM confidence
In this study, clinical remission after FMT was achieved in 54 (45%) of 119 patients... the pooled estimate for achieving clinical remission was 36.2%, when the case series were excluded... Although it might appear that FMT is more effective in CD or younger patients, the patient populations were significantly heterogeneous, limiting the applicability of these conclusions.
Hyun Ho Choi et al. · Clinical Endoscopy · 2016

Why this rating

Based on systematic reviews and meta-analyses, but limited by small sample sizes, heterogeneity, and publication bias.

Source

Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives

Hyun Ho Choi et al. · Clinical Endoscopy · 2016

DOI 10.5946/ce.2015.117

narrative_reviewCited 323×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →